BBA

BLB&B Advisors Portfolio holdings

AUM $2.73B Turnover 8.25%
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$462M
AUM Growth
-$5.66M
Cap. Flow
+$2.53M
Cap. Flow %
0.55%
Top 10 Hldgs %
24.77%
Holding
294
New
11
Increased
95
Reduced
121
Closed
12
Avg Time Held
1 year
Top 10 Avg Time Held
0.9 years
Top 20 Avg Time Held
1.1 years

Top Sells

Rank Stock Value
1
IONS icon
Ionis Pharmaceuticals
IONS
+$1.65M
2
RTX icon
RTX Corp
RTX
+$1.57M
3
WDC icon
Western Digital
WDC
+$754K
4
GLW icon
Corning
GLW
+$354K
5
AMLP icon
Alerian MLP ETF
AMLP
+$322K

Sector Composition

Rank Sector Weight
1 Technology 15.51%
2 Miscellaneous 15.12%
3 Industrials 14.31%
4 Healthcare 12.24%
5 Energy 10.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ZTS icon
76
Zoetis
ZTS
$31.1B
$1.64M 0.35%
44,383
+640
+1% +$21.9K
2013 Q3
4 quarters
VOD icon
77
Vodafone
VOD
$35.9B
$1.62M 0.35%
49,228
+14,418
+41% +$481K
2013 Q2
5 quarters
SYY icon
78
Sysco
SYY
$39.8B
$1.61M 0.35%
42,519
+3,438
+9% +$128K
2013 Q2
5 quarters
DHR icon
79
Danaher
DHR
$158B
$1.47M 0.32%
28,797
-1,651
-5% -$84.9K
2013 Q2
5 quarters
EMN icon
80
Eastman Chemical
EMN
$7.19B
$1.46M 0.32%
18,103
+135
+0.8% +$11.3K
2013 Q2
5 quarters
BIV icon
81
Vanguard Intermediate-Term Bond ETF
BIV
$28.2B
$1.46M 0.32%
17,322
+4,632
+37% +$392K
2013 Q2
5 quarters
PM icon
82
Philip Morris
PM
$320B
$1.41M 0.31%
16,945
-55
-0.3% -$4.65K
2013 Q2
5 quarters
WMB icon
83
Williams Companies
WMB
$89B
$1.39M 0.3%
25,140
-500
-2% -$28.7K
2013 Q2
5 quarters
CMCSA icon
84
Comcast
CMCSA
$74.7B
$1.36M 0.29%
50,704
+382
+0.8% +$10.5K
2013 Q2
5 quarters
BP icon
85
BP
BP
$126B
$1.36M 0.29%
37,725
+380
+1% +$15.1K
2013 Q2
5 quarters
SCHM icon
86
Schwab US Mid-Cap ETF
SCHM
$14.4B
$1.33M 0.29%
103,335
+300
+0.3% +$3.97K
2013 Q2
5 quarters
CVS icon
87
CVS Health
CVS
$116B
$1.33M 0.29%
16,692
-300
-2% -$23.6K
2013 Q2
5 quarters
KMB icon
88
Kimberly-Clark
KMB
$33.1B
$1.32M 0.29%
12,812
-21
-0.2% -$2.19K
2013 Q2
5 quarters
WTRG icon
89
Essential Utilities
WTRG
$11.3B
$1.21M 0.26%
51,542
+2,080
+4% +$50.8K
2013 Q2
5 quarters
BAC icon
90
Bank of America
BAC
$359B
$1.18M 0.26%
69,392
+4,807
+7% +$76.5K
2013 Q2
5 quarters
FCX icon
91
Freeport-McMoran
FCX
$100B
$1.16M 0.25%
35,527
+23,101
+186% +$839K
2013 Q2
5 quarters
RWJ icon
92
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$1.95B
$1.14M 0.25%
66,180
+7,350
+12% +$134K
2013 Q3
4 quarters
AEO icon
93
American Eagle Outfitters
AEO
$2.95B
$1.14M 0.25%
78,225
-1,800
-2% -$22.1K
2014 Q1
2 quarters
RWK icon
94
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.28B
$1.11M 0.24%
24,285
+3,840
+19% +$181K
2013 Q3
4 quarters
LQD icon
95
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.2B
$1.11M 0.24%
9,357
+1,475
+19% +$175K
2013 Q2
5 quarters
EWW icon
96
iShares MSCI Mexico ETF
EWW
$1.43B
$1.1M 0.24%
15,965
-35
-0.2% -$2.46K
2014 Q1
2 quarters
PAYX icon
97
Paychex
PAYX
$38.6B
$1.09M 0.24%
24,692
-2,425
-9% -$102K
2013 Q2
5 quarters
J icon
98
Jacobs Solutions
J
$16.6B
$1.06M 0.23%
26,285
-152
-0.6% -$6.63K
2013 Q2
5 quarters
EWY icon
99
iShares MSCI South Korea ETF
EWY
$22.8B
$1.02M 0.22%
16,870
– –
2014 Q1
2 quarters
COP icon
100
ConocoPhillips
COP
$171B
$1.01M 0.22%
13,197
+469
+4% +$38.4K
2013 Q2
5 quarters

Similar funds

BLB&B Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, BLB&B Advisors held 294 positions worth $462M, down 1.2% from $468M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

BLB&B Advisors's Q3 2014 filing shows 11 new, 95 increased, 121 reduced and 12 closed positions. Its largest new stake was Magnachip Semiconductor: 37,370 shares worth $437K. The largest sale was Ionis Pharmaceuticals, an estimated $1.65M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Industrials.

  • BLB&B Advisors's largest Q3 2014 buy was Magnachip Semiconductor: 37,370 shares worth $437K.
  • BLB&B Advisors added most to Vanguard FTSE Emerging Markets ETF in Q3 2014, an estimated $1.11M increase.
  • BLB&B Advisors's biggest Q3 2014 reduction was Ionis Pharmaceuticals, cutting an estimated $1.65M.
  • BLB&B Advisors fully exited Alerian MLP ETF in Q3 2014, selling an estimated $322K.
  • BLB&B Advisors's ten largest holdings make up 25% of its $462M portfolio in Q3 2014.
  • BLB&B Advisors opened 11 new positions and closed 12 in Q3 2014.
  • BLB&B Advisors's portfolio value fell 1.2% quarter-over-quarter to $462M.

Based on BLB&B Advisors's 13F filing for Q3 2014, filed 21 Oct 2014.